Literature DB >> 1328801

Enhanced tumor necrosis factor alpha in coronavirus but not in paracetamol-induced acute hepatic necrosis in mice.

D Devictor1, D Decimo, G Sebire, M Tardieu, M Hadchouel.   

Abstract

Previous reports have demonstrated that tumor necrosis factor alpha (TNF-alpha) plays an important role in the pathogenesis of fulminant hepatic necrosis. The purpose of this experimental study was to measure TNF-alpha blood activity in paracetamol-induced liver necrosis and in coronavirus (MHV3)-induced fulminant hepatitis in mice. No elevation of TNF-alpha activity was found in hepatic failure complicating paracetamol poisoning. In contrast, TNF-alpha activity significantly increased in response to MHV3, reaching 16.3 +/- 5.5 U/ml from 24 h post infection (P less than 0.01). This augmentation was observed even though the virus was not detectable in the liver. Serum alanine aminotransferase levels were low and no histological lesion was observed. In conclusion, our study further supports the implication of TNF-alpha in virus-induced hepatitis failure and confirms that paracetamol poisoning does not cause increased TNF-alpha activity in the circulation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328801      PMCID: PMC7165848          DOI: 10.1111/j.1600-0676.1992.tb01048.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  15 in total

Review 1.  Leukotrienes as mediators in diseases of the liver.

Authors:  D Keppler; M Huber; T Baumert
Journal:  Semin Liver Dis       Date:  1988-11       Impact factor: 6.115

2.  Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice.

Authors:  G Tiegs; M Wolter; A Wendel
Journal:  Biochem Pharmacol       Date:  1989-02-15       Impact factor: 5.858

3.  Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro.

Authors:  W Z Potter; D C Davis; J R Mitchell; D J Jollow; J R Gillette; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

4.  Selective tropism of a neurotropic coronavirus for ependymal cells, neurons, and meningeal cells.

Authors:  M Tardieu; O Boespflug; T Barbé
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

5.  Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection.

Authors:  M de la Mata; A Meager; N Rolando; H M Daniels; K T Nouri-Aria; A K Goka; A L Eddleston; G J Alexander; R Williams
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

6.  Tumor necrosis factor alpha stimulates leukotriene production in vivo.

Authors:  M Huber; B Beutler; D Keppler
Journal:  Eur J Immunol       Date:  1988-12       Impact factor: 5.532

7.  Toxic effects of recombinant tumor necrosis factor in suckling mice. Comparisons with interferon alpha/beta.

Authors:  I Gresser; D Woodrow; J Moss; C Maury; J Tavernier; W Fiers
Journal:  Am J Pathol       Date:  1987-07       Impact factor: 4.307

8.  Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure.

Authors:  Y Muto; K T Nouri-Aria; A Meager; G J Alexander; A L Eddleston; R Williams
Journal:  Lancet       Date:  1988-07-09       Impact factor: 79.321

9.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

Authors:  P P Nawroth; D M Stern
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

10.  Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.

Authors:  V Lehmann; M A Freudenberg; C Galanos
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

View more
  2 in total

1.  Toll-like receptor-2 exacerbates murine acute viral hepatitis.

Authors:  Christian Bleau; Mélanie Burnette; Aveline Filliol; Claire Piquet-Pellorce; Michel Samson; Lucie Lamontagne
Journal:  Immunology       Date:  2016-08-10       Impact factor: 7.397

2.  Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C.

Authors:  E Larrea; N Garcia; C Qian; M P Civeira; J Prieto
Journal:  Hepatology       Date:  1996-02       Impact factor: 17.425

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.